Pharmacologie spéciale - Macrolides
Pour en savoir plus
Articles de revue
- Van Bambeke F, Verhaegen J, Tyteca D, Auckenthaler R, Tulkens
PM. Erythromycine et néomacrolides actuels, usages clinique
et perspectives. Louvain Med 2000;119:259-286 (PDF)
- Zhanel GG, Dueck M, Hoban, DJ, Vercaigne LM, Embil JM, Gin AS,
Karlowsky JA. Review of macrolides and ketolides: focus on respiratory
tract infections. Drugs 2001;61(4):443-98.
Classification et propriétés de
base des macrolides
- Kirst HA. Semi-synthetic derivatives of erythromycin. Prog Med
Chem. 1993;30:57-88.
- Kirst HA, Sides GD. New directions for macrolide antibiotics:
pharmacokinetics and clinical efficacy. Antimicrob Agents Chemother.
1989 Sep;33(9):1419-22.
- Kirst HA, Sides GD. New directions for macrolide antibiotics:
structural modifications and in vitro activity.Antimicrob Agents
Chemother. 1989 Sep;33(9):1413-8.
Pharmacocinétique et pharmacodynamie
des macrolides: PM Tulkens (PDF)
Résistance
- Leclercq R. Mechanisms of resistance to macrolides and lincosamides:
nature of the resistance elements and their clinical implications.
Clin Infect Dis 2002;34:000-000.
- Resistance mechanisms: beta-lactams, macrolides and quinolones
(PDF)
- B. Vester, S. Douthwaite. Macrolide Resistance Conferred by Base
Substitutions in 23S rRNA. Atimicrob. Agents Chemother. 2001 45:1-12.
HTML: http://aac.asm.org/cgi/content/full/45/1/1?
PDF: http://aac.asm.org/cgi/reprint/45/1/1.pdf
- M.C. Roberts, J. Sutcliffe, P. Courvalin, L.B.Jensen, J. Rood,
& H. Seppala. Nomenclature for Macrolide and Macrolide-Lincosamide-Streptogramin
B ResistanceDeterminants Antimicrob. Agents Chemother. 1999 43:2823-30
HTML: http://aac.asm.org/cgi/content/full/43/12/2823?
PDF: http://aac.asm.org/cgi/reprint/43/12/2823.pdf
- Huovinen P, Seppala H, Kataja J, Klaukka T.The relationship between
erythromycin consumption and resistance in Finland. Finnish Study
Group for Antimicrobial Resistance. Ciba Found Symp. 1997;207:36-41;
discussion 41-6
- Weisblum B. Erythromycin resistance by ribosome modification.
Antimicrob Agents Chemother. 1995 Mar;39(3):577-85. http://aac.asm.org/cgi/reprint/39/3/577.pdf
- White L. Antibiotic resistance: where do ketolides fit? Pharmacotherapy
2002;22:18S-29S.
Utilisation clinique
- Alvarez-Elcoro S, Enzler MJ. The macrolides: erythromycin, clarithromycin,
and azithromycin. Mayo Clin Proc. 1999 Jun;74(6):613-34
- Boswell FJ, Wise R. Advances in the macrolides and quinolones.
Infect Dis Clin North Am. 1998 Sep;12(3):647-70
- Guay DR. Macrolide antibiotics in paediatric infectious diseases.
Drugs. 1996 Apr;51(4):515-36.
Kétolides
- Shain C. and Amsden G. Telithromycin: the first of the ketolides.
Ann Pharmacother 2002;36:452-64.
- Document de la FDA au sujet du lancement de la télithromycine
(lien)
|
